Avecho Biotechnology LimitedASX: AVE

Improved Propofol TPM Formulation Passes Toxicology Study

Nov 4, 2020 at 3:15 AM UTC · Issued by Avecho Biotechnology Limited

Avecho Biotechnology Ltd has released a press release.

View Attachment